Notice ID: 7de7cd019a46fb8804017a970380c9fcCombined Synopsis/Solicitation
65--MEDVAMC Hospital Wide Overhead Patient Lift Replacement AS A SET-ASIDE FOR SERVICE DISABLED VETERAN OWNED SMALL BUSI This RFQ will Close at 4:30PM CST on 09/27/2019. This is a Brand Name or Equal RFQ
Archived on November 11, 2019. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 12:00 AM UTC−05:00
- Posted
- September 26, 2019
- Notice type
- Combined Synopsis/Solicitation
- Set-aside
- Service-Disabled Veteran-Owned Small Business (SDVOSB) Set-Aside (FAR 19.14)
- NAICS
- 339112: Surgical and Medical Instrument Manufacturing
Notice details
- PSC
- 65: MEDICAL/DENTAL/VETERINARY EQPT/SUPP
- Last updated
- Dec 6, 2025
Identifiers
- Solicitation number
- 36C25619Q1534
- Notice ID
- 7de7cd019a46fb8804017a970380c9fc
Description
Page 1 of Page 81 of 81 Page 1 of (I) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR Subpart 12.6, as supplemented with additional information included in this notice and in accordance with the simplified acquisition procedures authorized in FAR Part 13. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. (II) This solicitation is issued as a request for quotation (RFQ). Submit written quotes on RFQ Number: 36C25619Q1534. (III) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2005-94, 2005-95 / 01-19-2019. (IV) This solicitation is being issued as Service Disabled Veteran Owned Small Business Set-Aside. The associated NAICS code is 339112. The small business size standard is 1000 EMPLOYEES (V) This combined solicitation/synopsis is for purchase of the following commercial services: Contractor shall furnish supplies as requested for the Michael E. DeBakey VA Medical Center, 2002 Holcombe Boulevard Houston, TX 77030
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
36C25619Q1534- Combined Synopsis
- 2×Combined SynopsisCurrentSep 24, 2019
65--MEDVAMC Hospital Wide Overhead Patient Lift Replacement AS A SET-ASIDE FOR SERVICE DISABLED VETERAN OWNED SMALL BUSI This RFQ will Close at 4:30PM CST on 09/27/2019. This is a Brand Name or Equal RFQ
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
6515--541-26-3-250-0303 - Olympus BX43 Pathology Microscope Brand Name Only Small Business Set-Aside Combined Synopsis/Solicitation Notice *= Required Field Combined Synopsis/Solicitation Notice DESCRIPTION This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Federal Acquisition Regulation (FAR) subpart 12.6, Streamlined Procedures for Evaluation and Solicitation for Commercial Items, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested, and a written solicitation document will not be issued. This solicitation is issued as an RFQ. The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2023-01. This solicitation is a Small Business set-aside. The associated North American Industrial Classification System (NAICS) code for this procurement is 339112. The FSC/PSC is 6515. The NCO 10 for Cleveland VA Medical Center is seeking to purchase the Olympus BX Microscope for the Cytology Department. This solicitation closes on September 25, 2026 @ 13:00 AM. Quotes should be submitted to Kevin Peeples kevin.peeples@va.gov Please reference 36C25026Q1066 1. Contracting Officer s Representative (COR NA 2. CONTRACT TITLE: BX43-1-3 Cytology Microscopes 3. BACKGROUND The Department of Veterans Affairs Northeast Ohio Healthcare System (VANEOHS) has an immediate requirement for the procurement of two (2) brand name Evident (formerly Olympus) BX43-1-3 cytology microscopes, inclusive of the True Color LED light source compatible with BX43F, BX46F, and BX63F platforms, and all required Original Equipment Manufacturer (OEM) components and accessories necessary for full clinical activation and use. The requested microscopes are additional units to the currently deployed Evident BX-series microscopes within the Cytology Section of Pathology & Laboratory Management Services (PALMS). The laboratory s diagnostic workflows, digital imaging systems, standardized operating procedures, educational protocols, and preventative maintenance programs are fully based upon the Evident BX-series platform. The Cytology laboratory s diagnostic workflows, digital imaging systems, standardized operating procedures, educational platforms, and preventative maintenance programs are built upon the BX-series architecture. The Cytology Section performs high-resolution visualization and evaluation of: Cellular morphology Cytological abnormalities Microbiological organisms Inflammatory processes Neoplastic pathologies These diagnostic evaluations are mission-critical to accurate, timely, and actionable patient diagnoses. This acquisition is required to maintain full operational capacity, mitigate diagnostic backlog, maximize utilization of existing Government-owned assets, and ensure uninterrupted cytopathology services. 4. SCOPE The Contractor shall provide two (2) new, current production BX43-1-3 microscopes, inclusive of the True Color LED light source and all requested and associated OEM components, accessories, modules, assemblies, and consumables required for immediate clinical deployment within the Cytology Section. The Contractor shall provide on-site installation, configuration, and operational verification of all microscopes and associated OEM components at the Louis Stokes Cleveland VA Medical Center, Pathology & Laboratory Management Services Cytology Section. Installation shall include full assembly, alignment of optical components, calibration of the illumination system, verification of mechanical stage functionality, confirmation of imaging integration (if applicable), and validation of overall system performance for clinical diagnostic use. All equipment shall be fully operational and ready for immediate patient care application upon completion of installation. Any deficiencies identified during installation or inspection shall be corrected by the Contractor at no additional cost to the Government prior to final acceptance. The microscopes and components shall meet or exceed the following operational, optical, interoperability, and performance requirements: Optical and Imaging Performance: UIS2 infinity-corrected optical system Plan Apochromat or Plan Fluorite objectives optimized for cytology applications High numerical aperture objectives suitable for oil immersion cytopathology 100x oil immersion capability Wide field number (FN 22 or greater) High-resolution visualization suitable for evaluation of cellular morphology, cytologic abnormalities, infectious organisms, and neoplastic processes OEM camera adapter compatibility for integration with existing digital imaging systems Illumination System: True Color LED light source compatible with BX43F, BX46F, and BX63F Daylight-balanced illumination to support accurate cytologic color interpretation Flicker-free, stable output LED lifespan 20,000 hours Intensity memory function Uniform illumination across full field of view Ergonomic and Mechanical Features: Ergonomic observation tube with adjustable inclination Low-position coaxial focus knobs Coarse and fine focus with tension adjustment Precision mechanical stage with fine movement control Stage inserts compatible with cytology slide preparation Configuration optimized for prolonged microscopic review Required OEM Accessories and Components: The Contractor shall provide all OEM components necessary to ensure full functionality and activation, including but not limited to: Proprietary stage inserts Light modules Camera adapters Immersion oil kits (OEM approved) Dust covers Power cords Calibration and setup materials Required mounting hardware Any additional OEM components necessary for clinical operation All components must be new, OEM-manufactured, and fully compatible with existing Evident BX-series microscopes currently deployed within the laboratory. Interoperability Requirements: The Cytology Section is standardized on the Evident BX-series microscope platform. All diagnostic workflows, imaging protocols, training materials, and maintenance programs are built upon this system. The requested microscopes are additional to the currently deployed fleet and must: Integrate seamlessly with existing BX-series equipment Maintain optical consistency across the microscope fleet Preserve manufacturer warranty protections Support existing service contracts and maintenance protocols Require no retraining due to platform change Non-OEM or alternate-brand equipment would: Disrupt standardized diagnostic workflow Introduce optical variability affecting diagnostic consistency Invalidate manufacturer warranties Require retraining of cytotechnologists and pathologists Undermine fleet uniformity and serviceability Warranty: Equipment shall include the manufacturer s standard warranty covering optical, mechanical, and illumination systems for a minimum of one (1) year. 6. Performance Monitoring The Government will monitor contractor performance to ensure compliance with all requirements outlined in this Statement of Work. Performance monitoring will include verification of timely delivery, proper installation, system functionality, completion of required training, and successful commissioning of the equipment in accordance with manufacturer specifications. Government representatives, including Pathology & Laboratory Medicine Service personnel and designated technical staff, will validate that the system operates as intended and meets operational and functional requirements prior to acceptance. Any deficiencies identified during delivery, installation, or operational verification shall be corrected by the Contractor at no additional cost to the Government. The Contractor shall coordinate all activities with the designated Government point of contact to ensure minimal disruption to laboratory operations and adherence to agreed installation schedules. 7. Security Requirements The C&A requirements do not apply, and the Security Accreditation package is not required for this SOW. 8. Government-Furnished Equipment (GFE)/Government-Furnished Information (GFI). There will be no government-Furnished equipment of information. 9. Other Pertinent Information or Special Considerations. The requested equipment shall be interoperable/usable with current workflows and technology deployed and used within the clinical atmosphere and existing BX Microscopes and associated accessories. a. Identification of Possible Follow-on Work. NA b. Identification of Potential Conflicts of Interest (COI). NA c. Identification of Non-Disclosure Requirements. NA d. Packaging, Packing and Shipping Instructions. NA e. Inspection and Acceptance Criteria. Government acceptance will occur upon: Successful installation Demonstrated operational functionality Completion of training if applicable Readiness for clinical laboratory use 10. Place of Performance. Delivery Location: Louis Stokes Cleveland VA Medical Center Pathology & Laboratory Management Services Cytology 10701 East Boulevard Cleveland, OH 44106 11. Period of Performance NA 12. Delivery Schedule. The Contractor shall deliver all required equipment and system components within ninety (90) calendar days from the date of contract award. Installation, configuration, and commissioning activities shall be coordinated with Government personnel and completed within the same 90-day period unless otherwise agreed upon in writing by the Contracting Officer. SUBMISSION Responses to this solicitation shall be submitted via email to kevin.peeples@va.gov. Telephone responses shall not be accepted. Responses must be received no later than September 25 2026, at 13:00 pm EST, (Eastern Standard Time). CLAUSES FAR Number Title Date 52.209-6 PROTECTING THE GOVERNMENT S INTEREST WHEN SUBCONTRACTING WITH CONTRACTORS DEBARRED, SUSPENDED, OR PROPOSED FOR DEBARMENT JAN 2025 52.212-4 CONTRACT TERMS AND CONDITIONS-- COMMERCIAL ITEMS NOV 2023 52.222-90 ADDRESSING DEI DISCRIMINATION BY FEDERAL CONTRACTORS APR 2026 52.232-33 PAYMENT BY ELECTRONIC FUNDS TRANSFER SYSTEM FOR AWARD MANAGEMENT OCT 2018 52.252-2 CLAUSES INCORPORATED BY REFERENCE FEB 1998 52.232-40 PROVIDING ACCELERATED PAYMENTS TO SMALL BUSINESS SUBCONTRACTORS MAR 2023 52.233-1 DISPUTES MAY 2014 52.233-3 PROTEST AFTER AWARD AUG 1996 852.219-76 852.203-70 VA NOTICE OF LIMITATIONS ON SUBCONTRACTING-CERTIFICATE OF COMPLIANCE FOR SUPPLIES AND PRODUCTS (DEVIATION) COMMERCIAL ADVERTISING JAN 2023 MAY 2018 852.232-72 ELECTRONIC SUBMISSION OF PAYMENT REQUESTS NOV 2018 852.237-70 CONTRACTOR RESPONSIBILITIES OCT 2019 PROVISIONS 52.212-1 INSTRUCTIONS TO OFFERORS-COMMERCIAL ITEMS SEP 2023 52.212-2 EVALUATION--COMMERCIAL ITEMS NOV 2021 | 66% | Combined Synopsis | 09/25/2026 |
Proposed procurement for NSN 6515015306147 INTRAOSSEOUS INFUSION: Line 0001 Qty 2 UI PG Deliver To: 0068 CS BN CO A COMPOSITE By: 0020 DAYS ADO Line 0002 Qty 1 UI PG Deliver To: 0051 MD CO MEDICAL LOGISTI By: 0020 DAYS ADO Line 0003 Qty 3 UI PG Deliver To: 0189 CS BN CO A COMPOSITE By: 0020 DAYS ADO Line 0004 Qty 1 UI PG Deliver To: 0129 CS BN CO A COMPOSITE By: 0020 DAYS ADO Line 0005 Qty 4 UI PG Deliver To: 0189 CS BN CO A COMPOSITE By: 0020 DAYS ADO Line 0006 Qty 1 UI PG Deliver To: 0087 CS BN CO A COMPOSITE By: 0020 DAYS ADO Line 0007 Qty 1 UI PG Deliver To: 0087 CS BN CO A COMPOSITE By: 0020 DAYS ADO Line 0008 Qty 1 UI PG Deliver To: 0142 CS BN CO A COMPOSITE By: 0020 DAYS ADO Line 0009 Qty 1 UI PG Deliver To: 0129 CS BN CO A COMPOSITE By: 0020 DAYS ADO Approved source is 8BXN8 01-0042RTR. The solicitation is an RFQ and will be available at the link provided in this notice. Hard copies of this solicitation are not available. Specifications, plans, or drawings are not available. All responsible sources may submit a quote which, if timely received, shall be considered. Quotes must be submitted electronically. | 65% | Combined Synopsis | 11/18/2026 |
Proposed procurement for NSN 6515016074332 HOSE ASSEMBLY,BLOOD PR: Line 0001 Qty 282 UI EA Deliver To: W1A8 DLA DISTRIBUTION By: 0082 DAYS ADO Approved source is 0UJ27 8300-0002-01. The solicitation is an RFQ and will be available at the link provided in this notice. Hard copies of this solicitation are not available. Specifications, plans, or drawings are not available. All responsible sources may submit a quote which, if timely received, shall be considered. Quotes must be submitted electronically. | 65% | Combined Synopsis | 11/17/2026 |
Proposed procurement for NSN 6515015183823 HEADLAMP,MEDICAL: Line 0001 Qty 3319 UI EA Deliver To: W1A8 DLA DIST SAN JOAQUIN By: 0090 DAYS ADO Approved source is 9X319 QUAD-TAC-BK. The solicitation is an RFQ and will be available at the link provided in this notice. Hard copies of this solicitation are not available. Specifications, plans, or drawings are not available. All responsible sources may submit a quote which, if timely received, shall be considered. Quotes must be submitted electronically. | 65% | Combined Synopsis | 10/19/2026 |
Proposed procurement for NSN 6515014495924 ADMINISTRATION SET,INT: Line 0001 Qty 4 UI PG Deliver To: 0548 CS BN CO A COMPOSITE By: 0020 DAYS ADO Line 0002 Qty 5 UI PG Deliver To: 0548 CS BN CO A COMPOSITE By: 0020 DAYS ADO Line 0003 Qty 192 UI PG Deliver To: 0548 CS BN CO A COMPOSITE By: 0020 DAYS ADO Approved sources are 1G026 2C6401; 30TR5 TICS.17.10302; 6ESG8 64546. The solicitation is an RFQ and will be available at the link provided in this notice. Hard copies of this solicitation are not available. Specifications, plans, or drawings are not available. All responsible sources may submit a quote which, if timely received, shall be considered. Quotes must be submitted electronically. | 63% | Combined Synopsis | 11/18/2026 |
Additional Details
Solicitation Number
36C25619Q1534
Archive Date
Nov 11, 2019